Winning patients and consumers with safe and convenient unpreserved ophthalmic products.
Ophthalmic diseases such as Age-related Macular Degeneration (AMD) and Glaucoma are potentially chronic conditions, requiring life-long medical therapy. Failure by the patient to adhere to a proper treatment regimen may lead to disease progression and visual loss, in addition to all of the consequences around quality of life and capacity to work.
Poor compliance is widespread and is often due to a combination of factors, including drops that sting and the difficulty of applying drops accurately, especially for older patients. Preservatives play a prominent role in this unpleasant experience.
And, of course, no one wants compromise when it comes to microbiological integrity.
This webinar presents a review of the available options in Eye Care and discusses future trends, in particular preservatives, debatable additives, and progressive initiatives such as ‘connected Eye Care’, a technology that is gaining even more traction during the pandemic.
Finally, we will present our thoughts on strategies to address patient compliance in clinical settings as well as in the homecare environment, and regulatory hurdles to overcome.
Presented by
Matthias Birkhoff,
Vice President, Business Development
Matthias Birkhoff is Vice President, Business Development, Aptar Pharma Consumer Healthcare. He is responsible for Aptar Pharma’s Eye Care program and coordinates research and development activities, as well as commercial strategies.
Matthias Birkhoff’s LinkedIn Profile
Miriam Faude,
Product Manager OSD
Miriam Faude is Product Manager for the Ophthalmic Squeeze Dispenser at Aptar Pharma Consumer Healthcare.
Miriam Faude’s LinkedIn Profile
Dr Degenhard Marx,
Director Scientific Affairs Consumer Health Care Division
Dr Degenhard Marx is Director of Scientific Affairs at Aptar Pharma Consumer Healthcare.
Degenhard Marx’s LinkedIn Profile
